{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:52Z","timestamp":1790916952464,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent evidence has demonstrated that both donor- and recipient-derived immune cell subpopulations play a crucial role in various immune responses following allogeneic hematopoietic stem cell transplantation (HSCT). In this retrospective single center analysis, we investigated whether different lymphocyte subpopulations in the bone marrow (BM) of the recipient prior to HSCT might have an impact on outcome parameters after HSCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      BM aspirates of 140 patients &amp;gt; 18 years of age receiving a HSCT between 2008 and 2022 were analyzed. BM aspiration was performed within 3 months prior to HSCT. Median time from aspiration to HSCT was 14 days (range 8\u2013104 days). Lymphocyte subpopulations included CD19\n                      <jats:sup>+<\/jats:sup>\n                      B cells, CD56\n                      <jats:sup>+<\/jats:sup>\n                      NK cells, CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>-<\/jats:sup>\n                      CD8\n                      <jats:sup>-<\/jats:sup>\n                      T cells and CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High total lymphocytes &amp;gt; 37.35% (of leukocytes) correlated with an increased non-relapse mortality (NRM) at day 100 after HSCT, whereas high CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells &amp;gt; 69.45% (of lymphocytes) and CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells &amp;gt; 46.3% were associated with an increased risk for CMV infection. High NK cells &amp;gt; 8.8% resulted in an increased incidence for acute graft-versus host disease (GvHD). High CD19\n                      <jats:sup>+<\/jats:sup>\n                      B cells &amp;gt; 13.1% resulted in a decreased incidence of chronic GvHD. In contrast, high CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells &amp;gt; 49.3% were associated with an increased incidence of chronic GvHD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Recipient-derived lymphocyte subpopulations within the BM prior to HSCT comprise the prognostic potential to assess post-HSCT related outcome parameters. In summary, a shift towards humoral immunity with a BM characterized by a B cell enriched and T cell\/NK cell depleted microenvironment appears to be associated with a lower risk for post-HSCT complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1910059","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:41:20Z","timestamp":1790916080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Stefan","family":"Koeck","sequence":"first","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Hetzenauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josia","family":"Fauser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Petzer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieghart","family":"Sopper","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]},{"name":"Tyrolean Cancer Research Institute","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Peschel-Schaar","sequence":"additional","affiliation":[{"name":"Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nachbaur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normann","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck","place":["Innsbruck, Tyrol, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2018.09.011","article-title":"Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%","volume":"31","author":"Barrett","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1100306","article-title":"Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges","volume":"14","author":"Balakrishnan","year":"2023","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128982","article-title":"Pre-transplant CRP-albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.trim.2025.102211","article-title":"Pre-transplant and transplant parameters predict long-term survival after hematopoietic cell transplantation using machine learning","volume":"90","author":"Asteris","year":"2025","journal-title":"Transpl Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5045\/br.2023.2022192","article-title":"Effects of immune system cells in GvHD and corresponding therapeutic strategies","volume":"58","author":"Tavaf","year":"2023","journal-title":"Blood Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00184","article-title":"A T cell view of the bone marrow","volume":"7","author":"Bonomo","year":"2016","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jaci.2017.12.983","article-title":"A comparative analysis of human bone marrow-resident and peripheral memory B cells","volume":"141","author":"Becker","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: A report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41408-023-00951-2","article-title":"Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index","volume":"13","author":"\u00d3skarsson","year":"2023","journal-title":"Blood Cancer J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.08.005","article-title":"Host-derived CD8+ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"20","author":"Weber","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00093","article-title":"Dendritic cell regulation of graft-vs.-host disease: Immunostimulation and tolerance","volume":"10","author":"Yu","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082051","article-title":"Hematopoietic dysfunction during graft-versus-host disease: A self-destructive process","volume":"10","author":"M\u00fcskens","year":"2021","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1691","article-title":"Concise review: the bone marrow niche as a target of graft versus host disease","volume":"32","author":"von Bonin","year":"2014","journal-title":"Stem Cells"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141831","article-title":"Impact of the recipient's pre-treatment blood lymphocyte count on intended and unintended effects of anti-T-lymphocyte globulin in allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Nikoloudis","year":"2023","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1464096","article-title":"Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1038\/s41467-019-11947-7","article-title":"Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1182\/blood-2023-182920","article-title":"Double-negative T cells attenuate acute graft-versus-host disease by modulating CD4 + T cell activation post-allo-HSCT","volume":"142","author":"Pan","year":"2023","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbmt.2018.09.008","article-title":"Double-negative T cell levels correlate with chronic graft-versus-host disease severity","volume":"25","author":"Hillhouse","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.015","article-title":"Recipient B cells are not required for graft-versus-host disease induction","volume":"16","author":"Matte-Martone","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01937","article-title":"Evidence for B cell exhaustion in chronic graft-versus-host disease","volume":"8","author":"Khoder","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253559","article-title":"Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation","volume":"115","author":"Shono","year":"2010","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005644","article-title":"Activated B cells suppress T-cell function through metabolic competition","volume":"10","author":"Imahashi","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0328","article-title":"Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease","volume":"104","author":"Anderson","year":"2004","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-290403","article-title":"Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new","volume":"117","author":"Coghill","year":"2011","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:41:25Z","timestamp":1790916085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2026.1910059"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1910059","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1910059"}}